- Home
- JTAI vs ADXN Comparison
JTAI vs ADXN Comparison
Compare JTAI & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JTAI
- ADXN
- Stock Information
- Founded
- JTAI 2018
- ADXN 2002
- Country
- JTAI United States
- ADXN Switzerland
- Employees
- JTAI N/A
- ADXN N/A
- Industry
- JTAI Blank Checks
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- JTAI Finance
- ADXN Health Care
- Exchange
- JTAI Nasdaq
- ADXN Nasdaq
- Market Cap
- JTAI 9.9M
- ADXN 8.1M
- IPO Year
- JTAI N/A
- ADXN N/A
- Fundamental
- Price
- JTAI $3.60
- ADXN $9.20
- Analyst Decision
- JTAI
- ADXN Strong Buy
- Analyst Count
- JTAI 0
- ADXN 1
- Target Price
- JTAI N/A
- ADXN $30.00
- AVG Volume (30 Days)
- JTAI 329.3K
- ADXN 13.1K
- Earning Date
- JTAI 08-13-2025
- ADXN 06-19-2025
- Dividend Yield
- JTAI N/A
- ADXN N/A
- EPS Growth
- JTAI N/A
- ADXN N/A
- EPS
- JTAI N/A
- ADXN 0.10
- Revenue
- JTAI $13,648,668.00
- ADXN $278,508.00
- Revenue This Year
- JTAI $13.37
- ADXN $86.57
- Revenue Next Year
- JTAI $201.13
- ADXN N/A
- P/E Ratio
- JTAI N/A
- ADXN $0.76
- Revenue Growth
- JTAI N/A
- ADXN N/A
- 52 Week Low
- JTAI $2.30
- ADXN $6.51
- 52 Week High
- JTAI $97.40
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- JTAI 42.57
- ADXN 60.47
- Support Level
- JTAI $3.41
- ADXN $8.50
- Resistance Level
- JTAI $3.95
- ADXN $9.78
- Average True Range (ATR)
- JTAI 0.25
- ADXN 0.73
- MACD
- JTAI 0.00
- ADXN 0.07
- Stochastic Oscillator
- JTAI 22.54
- ADXN 85.39
About JTAI Jet.AI Inc.
Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.